SEE THE STEWARDSHIP BIG PICTURE, WITHOUT MISSING THE DETAILS

2:00pm - 3:00pm AEDT | Thursday, 3rd March 2022

Change is the only constant in infectious diseases. With the stress of a global pandemic, supply-chain uncertainty, and notoriously complex data, health-systems and laboratories face unprecedented challenges to deliver timely actionable data to tell compelling stories that drive strategic responses and meaningful improvements. The solution must be Built to the Need. CLARION (TM) breaks the silos between tests, instruments and vendors, while bridging the gaps between laboratory, institution and leadership.

View Session Recording

Speaker | Dr Frances Valencia-Shelton

Dr. Valencia-Shelton PhD, D(ABMM), SM(ASCP) received her undergraduate degree in Biology from St Mary’s University in San Antonio Tx and her Ph.D. in Experimental Pathology from The University of Texas Medical Branch in Galveston, Texas. She also completed a fellowship in Medical Microbiology and Public Health at the University of Rochester in Rochester, New York.

Dr. Valencia Shelton is the Clinical Infectious Diagnostics Director for the Baptist Health System. She is also a Diplomate of the American Board of Medical Microbiology. She oversees the scientific direction and operation of the Infectious Diagnostics Laboratory.

Her interests include defining and utilizing clinical best-practice for testing and reporting, optimizing current and discovering new infectious diagnostic testing methodologies for patient-centered clinical testing through cost-effective measures. She is equally interested in educating others in the field of clinical microbiology.

Speaker | Dr John Hurst

Dr. John Hurst, PharmD, BCIDP graduated in 2010 from the University of Oklahoma College of Pharmacy. He then spent the next year in Birmingham, Alabama completing the PGY-1 Pharmacy Practice Residency at the 1100-bed UAB Hospital. From there he continued east to Charleston, South Carolina where he completed a PGY-2 Infectious Diseases Pharmacy Residency at the Medical University of South Carolina (MUSC), under the guidance of mentors Dr. John Bosso and Dr. Lisa Steed. MUSC hired Dr. Hurst as a Clinical Pharmacy Specialist of Infectious Diseases following his residency. 

For two and a half years Dr. Hurst transformed and expanded the Antimicrobial Stewardship Program (ASP) at MUSC. During his tenure, the ASP grew with the addition of a second full time stewardship pharmacist, presented and published ASP research. In 2015, Dr. Hurst joined SSM Health’s St. Anthony Hospital in Oklahoma City where he started a new Antimicrobial Stewardship Program. In October 2016, Dr. Hurst was promoted to Director of Antibiotic Stewardship. In November 2016 The Oklahoma Hospital Association recognized Dr. Hurst with the Spirit of Improving Patient Safety Award for his work implementing a clinical bacteremia treatment pathway based on rapid multiplex PCR results. 

In 2018, Dr. Hurst joined bioMérieux as Senior Director of U.S. Antimicrobial Stewardship. Three years later, Dr. Hurst guides a dynamic team of Board Certified Infectious Diseases Pharmacists to aid hospitals and laboratories in capturing the value of diagnostics and health data to impact patient care, prevent the spread of Antimicrobial Resistance (AMR), and achieve financial sustainability and success.

Moderator | Dr Carla Lee Lau

Dr Carla Lee Lau is the medical director for bioMérieux Australia and New Zealand. While at bioMérieux, Carla has held various positions including Asia Pacific regional responsibility overseeing Respiratory Solutions product portfolio which includes SARS-CoV-2 diagnostics and served as a Medical Education Liaison in the United States. As a member of the clinical team she enjoys working closely with clinicians, hospital infection control, and antimicrobial stewardship committees to better understand diagnostic utility and its role in early identification of infectious disease trends in our community and impact on optimizing antimicrobial use. 

She is passionate about infectious diseases and started her career in New York City working for the Department of Health and at NYU Langone Medical Center Division of Pediatric Infectious Diseases. At NYU she help manage PHACS, Pediatric HIV/AIDS Cohort Study, a US National Institute of Health funded study investigating the long term effects of HIV infection and anti-retroviral medications in children and young adults who were born or born exposed to HIV. She is a member of both Infectious Diseases Society of America and American Public Health Association.